Showing results (1-10 of 272) with videos related to

Sort By:
Pageof 28
American Journal of Obstetrics and Gynecology|July 1, 1990
Interrelations between carbohydrates, lipids, and the hemostatic system in relation to the risk of thrombotic and cardiovascular diseaseI Juhan-Vague, P Vague
Nouvelle Revue Francaise D'Hematologie|January 1, 1982
[Erythrocyte and platelet parameters and degree of control of diabetes]I Juhan-Vague, P Vague
Diabete & Metabolisme|May 1, 1991
Hypofibrinolysis and insulin-resistanceI Juhan-Vague, P Vague
Metabolism: Clinical and Experimental|May 1, 1992
Hemobiology, vascular disease, and diabetes with special reference to impaired fibrinolysisP Vague, D Raccah, I Juhan-Vague
Annals of Medicine|August 1, 1996
Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitusI Juhan-Vague, M C Alessi, P Vague
Diabetologia|July 1, 1991
Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosisI Juhan-Vague, M C Alessi, P Vague
Metabolism: Clinical and Experimental|September 1, 1989
Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese womenP Vague, I Juhan-Vague, V Chabert, et al.
The Journal of Clinical Investigation|May 1, 1993
Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulinF Anfosso, N Chomiki, M C Alessi, et al.
Pathologie-Biologie|October 1, 1988
[The effect of pentoxifylline and propentofylline on the membrane fluidity of red blood cells in uncontrolled insulin-dependent (type 1) diabetic patients]C Roul, I Juhan-Vague, D Rahmani-Jourdheuil, et al.
Thrombosis and Haemostasis|June 3, 1987
Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjectsP Vague, I Juhan-Vague, M C Alessi, et al.
Pageof 28